Public Profile

Allergan, Inc.

Allergan, Inc., a prominent player in the global pharmaceutical industry, is headquartered in the United States. Founded in 1948, the company has established itself as a leader in medical aesthetics, eye care, and neuroscience, with significant operations across North America, Europe, and Asia. Allergan is renowned for its innovative products, including the iconic Botox, which revolutionised cosmetic treatments, and a diverse portfolio of therapeutic solutions. The company’s commitment to research and development has led to numerous breakthroughs, solidifying its market position as a trusted provider of advanced healthcare solutions. With a focus on enhancing patient outcomes, Allergan continues to achieve notable milestones, making it a key player in the ever-evolving pharmaceutical landscape.

DitchCarbon Score

How does Allergan, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

35

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Allergan, Inc.'s score of 35 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.

66%

Let us know if this data was useful to you

Allergan, Inc.'s reported carbon emissions

Allergan, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). Additionally, there are no documented climate commitments or initiatives aimed at reducing greenhouse gas emissions. As a result, Allergan's climate strategy and its alignment with industry standards remain unclear. The absence of data highlights a potential area for improvement in transparency regarding their environmental impact and sustainability efforts.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Allergan, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Allergan, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Allergan, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Coty

US
Wearing apparel; furs (18)
Updated 19 days ago

Lannett Company, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Alcon Laboratories, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Pharmacosmos

DK
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

ANI Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Supernus Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers